EXECUTIVE ADVISORY BOARD
The CLP Executive Advisory Board (EAB) is integral to the growth and success of the Institute. Founded in 2005, the Board includes business leaders, entrepreneurs, researchers, physicians and tech experts. The EAB provides members with a gateway to the world of transdisciplinary biomedical discovery, innovation and education. Board members contribute their individual strengths to the Institute in the form of business advice and assistance in commercializing innovations, insight into educational programs, feedback on operations, strategic plans, marketing, fundraising, and individual philanthropy.
Vice President, Chief US Commercial Counsel, Biogen Idec
Vice President, Product Development and Analytics, Cour Pharmaceutical Development Company, Inc.
CEO, Euronet Worldwide
Senior Vice President of Research Biology, Genentech
COO, Hilco Global
Managing Director, AnswerMine
Co-founder, President, CEO and Board Member, Medeor Therapeutics
Principal, Round Lake Designs
Founder and Managing Director, High Country Venture
Principal, Martin Investment Management, LLC
CFO, Chief Strategy Officer, Cara Therapeutics
Christopher J. O'Connell
Chairman and CEO, Waters Corporation
Founder, The O'Shea Firm
Director of Clinical Research, Cytokinetics, Inc.
CEO, Monopar Therapeutics
Tracy Schwartz Ward
Principal, Schwartz Capital Group
President and CEO, CymaBay Therapeutics
Myung K. Shin
Executive Director, Head of Early Discovery Genetics, Genetics and Pharmacogenomics, Merck & Co., Inc.
Chief Medical Officer, Finch Therapeutics, Inc.
Senior Director, Gene Therapy, Sarepta Therapeutics